Sarepta Therapeutics, Inc. SRPT Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s payments to acquire property, plant, and equipment?
- Sarepta Therapeutics, Inc. (SRPT) reported payments to acquire property, plant, and equipment of $2.08M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s payments to acquire property, plant, and equipment changed year-over-year?
- Sarepta Therapeutics, Inc.'s payments to acquire property, plant, and equipment decreased by 95.2% year-over-year, from $43.65M to $2.08M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s payments to acquire property, plant, and equipment?
- Over 4 years (2021 to 2025), Sarepta Therapeutics, Inc.'s payments to acquire property, plant, and equipment has grown at a 27.6% compound annual growth rate (CAGR), from $38.49M to $101.97M.